Areas of Focus

Breast cancer is a complex disease with no simple solution. That's why our researchers are tackling it from every angle. Learn more about our areas of focus and why each is critical to knowing how to fight cancer from the start, slow its progress and one day stop it from occurring altogether.

Treatment

Every cancer is as unique as each patient. Thanks to research, we now know that no two cancers are the same and have evolved from a one-size-fits-all approach to treatment to tailored therapies and more effective drugs. With more personalized treatment comes improved outcomes.

Our researchers know that a treatment’s benefits, as well as its risks, differ for each person. The type of breast cancer, the stage of the disease and the characteristics of the tumor, along with one’s lifestyle and medical history, are all taken into consideration. Our aim? To find the least invasive, most effective option that will minimize adverse effects while maximizing success for each patient. We like to call this “outsmarting cancer.”

Dr. Aaronson’s research is focused on discovery and functions of cancer genes. At the NCI as Chief, Laboratory of Cellular and Molecular Biology, he identified the first normal function of a cancer gene as that of a growth factor, PDGF, and cloned erbB2 (also...

Mohamed received his B.S. degree in Biochemistry in 2000 and his MD, PhD degree in 2008 from the University of Michigan. His early research  focused on developing facile assays to resolve complex fundamental cellular processes. He is trained in genetics,...

Kathy S. Albain is Professor of Medicine (tenured) at Loyola University Chicago Stritch School of Medicine and is a Dean’s Senior Scholar. As a member of the Division of Hematology/Oncology, she devotes her clinical practice to patients with breast and lung cancer at...

Fabrice André MD, PhD, is an oncologist based at Gustave Roussy Cancer Cancer, Villejuif, France. He is Professor of Medicine at University Paris Sud. His BCRF research focuses on the characterisation of molecular alterations in metastatic breast cancers. He is leading...

Michael Andreeff received his MD and PhD from the University of Heidelberg, Germany, and additional training at Memorial Sloan Kettering Cancer Center. He has been a pioneer in flow cytometry since 1971, when he established the first flow cytometry laboratory at the...

Dr. Arteaga is Professor of Medicine and Director of the Simmons Cancer Center at University of Texas, Southwestern Medical Center. He was formally Associate Director for Clinical Research, Director of the Breast Cancer Program, and Director of the Center for Cancer...

Dr. Tarah Ballinger received her bachelor’s degree from the University of Notre Dame and her MD from Indiana University. She completed her internal medicine residency at Vanderbilt University and her oncology fellowship at Indiana University before joining the faculty...

Robert Benezra, PhD, is a Member at Memorial Sloan Kettering Cancer in the Department of Cell Biology and a Professor of Biology at Cornell Graduate School of Medical Sciences in New York City. As a postdoctoral fellow he identified the Id proteins as dominant negative...

Dr. Joseph R. Bertino attended Cornell University and Downstate Medical School, SUNY. After internship and residency, he was a Fellow in Hematology and Biochemistry at The University of Washington. In 1961, he joined the faculty at Yale in Pharmacology/Medicine where...

Laura Biganzoli is the Director of the Breast Center at the Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. She earned her medical degree at the University of Pavia, Italy, and completed fellowships at the National Cancer Institute of Milan and at the Jules...

Dr. Myles Brown is Director of the Center for Functional Cancer Epigenetics at the Dana-Farber Cancer Institute and Professor of Medicine at Harvard Medical School. He obtained his BS in Biology from Yale and his MD from Johns Hopkins. Following training in internal...

Powel Brown is a medical oncologist and physician-scientist specializing in breast cancer treatment and prevention at the University of Texas, MD Anderson Cancer Center, where he is Chair of the Department of Clinical Cancer Prevention. He is conducting studies to...

Dr. Brugge is Co-Director of the Ludwig Center at Harvard Medical School. A graduate of Northwestern University, she did graduate work at the Baylor College of Medicine, completing her PhD in 1975, followed by postdoctoral training at the University of Colorado with Dr...

Dr. Isaac S. Chan received his Bachelor of Science in Engineering degree from Duke University in 2005 and then went on to pursue a dual MD/PhD degree from the University of North Carolina, where he was a James Moses and Stella Frosst Alexander Scholar. In the lab of Dr...

Sarat Chandarlapaty, MD, PhD, is an Associate Attending medical oncologist and a Laboratory Head in the Human Oncology and Pathogenesis Program at Memorial Sloan Kettering Cancer Center. He earned his medical degree at the Wake Forest School of Medicine and his PhD at...

Dr. Chang obtained medical degree from Cambridge University, England and completed fellowship in medical oncology at the Royal Marsden Hospital/Institute for Cancer Research. She was awarded research doctorate from the University of London. Breast cancer has been the...

Michael Clarke, MD is a Professor of Medicine at Stanford University. He is the Karel and Avice Beekhuis Professor in Cancer Biology and Associate Director of the Stanford Institute for Stem Cell Biology and Regenerative Medicine. His interest is in Stem Cell Biology....

Dr. Elizabeth Comen is a medical oncologist at Memorial Sloan Kettering Cancer Center with a practice devoted to the study and treatment of patients with all stages of breast cancer. Dr. Comen earned her BA from Harvard College and her MD from Harvard Medical School....

Dr. Cortez graduated summa cum laude from the University of Illinois at Champaign-Urbana with Highest Honors in Biology and Biochemistry. He received his doctorate in 1997 in Molecular Cancer Biology from Duke University. After postdoctoral training as a Jane Coffin...

Jack Cuzick, PhD is Director of the Wolfson Institute of Preventive Medicine in London. He is also head of the Centre for Cancer Prevention and John Snow Professor of Epidemiology at Queen Mary, University of London. He holds a PhD in Mathematics and has previously...

Fifteen years ago, Alan D’Andrea began to study the molecular pathogenesis of Fanconi Anemia (FA), a human genetic disease characterized by bone marrow failure, cancer susceptibility, and cellular hypersensitivity to DNA crosslinking agents. Dr. D’Andrea’s laboratory...

Sandra Demaria, MD, a native of Turin, Italy, obtained her MD from the University of Turin. She then moved to New York City for her post-doctoral training in immunology as a Damon Runyon-Walter Winchell Cancer Research Fund awardee, followed by a residency in anatomic...

Angela DeMichele, MD, MSCE, is a Professor of Medicine and Epidemiology at the University of Pennsylvania and holds the Jill and Alan Miller Endowed Professorship in Breast Cancer Excellence. Dr. DeMichele has been the Co-Leader of the Breast Cancer Research Program in...

Angelo Di Leo is Head of the Sandro Pitigliani Medical Oncology Department at the Hospital of Prato, Istituto Toscano Tumori, Italy, since September 2003. He trained at the National Cancer Institute in Milan, where he worked for seven years. From 1996 to 2003, he...

Mary L. (Nora) Disis, MD, is the Athena Distinguished Professor of Breast Cancer Research, Associate Dean for Translational Health Sciences in the University of Washington (UW) School of Medicine, Professor of Medicine and Adjunct Professor of Pathology and Obstetrics...

Professor Mitch Dowsett, FMedSci, PhD, is Head of the Academic Department of Biochemistry and Head of the Centre for Molecular Pathology at the Royal Marsden Hospital; Professor of Biochemical Endocrinology at the Institute of Cancer Research; and Professor of...

Shelton Earp is the Lineberger Professor of Cancer Research, Director of UNC Cancer Care and former Director of the UNC Lineberger Comprehensive Cancer. In these roles, he has helped develop basic, clinical and public health research and cancer care at one of the...

Originally from the United Kingdom, Matthew Ellis completed his medical training in the U.K. at the Universities of Cambridge and London.  After 11 years at Washington University in St Louis, Dr. Ellis is the incoming Director of the Lester and Sue Smith Breast...

Dr. Stanislav Emelianov is a Joseph M. Pettit Endowed Chair, Georgia Research Alliance Eminent Scholar, and Professor of Biomedical Engineering and Electrical & Computer Engineering at the Georgia Institute of Technology. He is also appointed at Emory University...

Leisha Emens is a Professor of Medicine at the UPMC Hillman Cancer Center. She serves as Co-Leader of the Hillman Cancer Immunology and Immunotherapy Program, and Director of Translational Immunotherapy for the Magee Women's Cancer Research Center....

Dr. Esserman is a surgeon and breast cancer oncology specialist, and is the Director of the Carol Franc Buck Breast Care Center at the University of California, San Francisco (UCSF).  In 1996, she started the Center of Excellence for Breast Cancer Care at...

Zhen Fan was awarded his medical degree in 1985 from the Medical School of Shanghai Medical University, one of China’s most prestigious medical schools, and completed additional graduate studies there in 1988. His medical residency and oncology research training were...

Dr. Rena Feinman is an Associate Scientist in the Department of Research and Member of the John Theurer Cancer Center at Hackensack University Medical Center. She received her PhD in the Department of Microbiology at the New York University School of Medicine and...

Dr. Silvia C. Formenti, an international expert in the use of radiation therapy for the treatment of cancer, is Chair of the newly established Department of Radiation Oncology at Weill Cornell Medical College and Radiation Oncologist-in-Chief at New York-Presbyterian/...

Dr. Monica Fornier is an Associate Member at the Breast Medicine Service of Memorial Sloan Kettering Cancer Center and Assistant Professor at Weil Cornell Medical College. She specializes in the treatment of breast cancer. She is also an Assistant Professor at the...

Prue Francis is Clinical Head of Breast Medical Oncology at Peter MacCallum Cancer Centre in Melbourne, Australia. She received her medical degree from the University of Melbourne and completed Medical Oncology training at Memorial Sloan-Kettering Cancer Center in New...

Dr. Fuqua has a Bachelor's degree and a Master's Degree from the University of Houston. Her PhD is in Cancer Biology from the University of Texas Graduate School of Biomedical Science. She is a Professor of Medicine and Molecular and Cellular Biology at Baylor College...

Dr. Shridar Ganesan is the Associate Director for Translational Science at the Rutgers Cancer Institute of New Jersey, Chief of the Section of Molecular Oncology, and Associate Professor of Medicine at the Rutgers Robert Wood Johnson Medical School. Dr. Ganesan...

Dr. Gianni is the Director of the Department of Medical Oncology and the head of the Project of Development of New Drugs and Innovative Therapies in Solid Tumours at the San Raffaele Scientific Institute in Milan, Italy. He also is the Cofounder and President of the...

Mehra Golshan, MD, a breast surgical oncologist and is the inaugural and incumbent Dr. Abdul Mohsen and Sultana Al-Tuwaijri Distinguished Chair in Surgical Oncology, Director of Breast Surgical Oncology Fellowship and Associate Professor of Surgery at Harvard Medical...

Pamela Goodwin has been involved in research relating to host factors in breast cancer for over 25 years. Early in her career, she became intrigued with the possibility that patient-related factors, especially obesity, might impact outcomes of women diagnosed with...

William J. Gradishar is Betsy Bramsen Professor of Breast Oncology in the Division of Hematology and Medical Oncology at the Feinberg School Medicine at Northwestern University and a member of the Robert H. Lurie Comprehensive Cancer Center. He is Director of the...

Julie R. Gralow, MD, is the Jill Bennett Endowed Professor of Breast Cancer at the University of Washington (UW) School of Medicine, Director of Breast Medical Oncology at the Seattle Cancer Care Alliance, and Member of the Clinical Research Division at Fred Hutchinson...

Mark I. Greene received his MD and PhD from the University of Manitoba in Canada, and the FRCP from the Royal College in 1976. In 1976 Dr. Greene moved from Canada to Harvard University. Professor Greene was appointed Assistant Professor at Harvard Medical School in...

Dr. Haber is Director of the Massachusetts General Hospital Cancer Center and the Kurt J. Isselbacher Professor of Oncology at Harvard Medical School. His laboratory interests have focused on the area of cancer genetics, including the etiology of the pediatric kidney...

Bruce G. Haffty, MD is Professor and Chairman, Department of Radiation Oncology, Rutgers-Robert Wood Johnson Medical School and New Jersey Medical School and Associate Director, Rutgers Cancer Institute of New Jersey. His medical school training, internship, residency...

Daniel Hayes, MD, is the Clinical Director of the Breast Oncology Program at the University of Michigan Comprehensive Cancer Center (UMCCC) and the Stuart B. Padnos Professor of Breast Cancer Research. He received AB (1974) and MS (1977) degrees at Indiana University,...

Dr. Hicks is a molecular geneticist using genomics to study the initiation and progression of cancer in human patients with the goal of developing clinical assays for improving the treatment of the disease.  His current studies expand on his previous work on the...

William Holloman, PhD has been a professor at the Weill Cornell Medical College for nearly thirty years. He studies genetic recombination, a molecular mechanism that moves genes around and also repairs DNA damage. This is an essential operation that cells use to...

Dr. Gabriel Hortobagyi is an internationally recognized expert in clinical and translational research of breast cancer. He is Professor and the Chair Emeritus of the Department of Breast Medical Oncology at the MD Anderson Cancer Center. He was Hematology/Oncology...

Dr. Susan Band Horwitz is a Distinguished University Professor at the Albert Einstein College of Medicine. She grew up in Boston and after graduating from Bryn Mawr College, received her PhD in Biochemistry from Brandeis University.Dr. Horwitz has had a continuing...

Hedvig Hricak is Chair of the Department of Radiology, Memorial Sloan Kettering Cancer Center, a member of the Molecular Pharmacology and Chemistry Program, Sloan Kettering Institute, and Professor, Gerstner Sloan Kettering Graduate School of Biomedical Sciences. The...

Mien-Chie Hung, Ph.D. is the President for China Medical University in Taichung, Taiwan. He was vice president for basic research and professor and chair of the Department of Molecular and Cellular Oncology at The University of Texas MD Anderson Cancer Center. He...

Dr. Ince received his PhD in Pharmacology from Cornell and completed clinical training at Massachusetts General Hospital, Brigham and Women's Hospital, and Harvard Medical School. Dr. Ince was a visiting clinical scientist at Massachusetts Institute of Technology, 2000...

James N. Ingle, MD is Professor of Oncology and Foust Professor in Mayo Clinic College of Medicine. He is the leader of breast cancer research in the Mayo Clinic Comprehensive Cancer Center serving as Program Co-Leader of the Women's Cancer Program with responsibility...

Dr. Irie is Assistant Professor of Medicine and Oncological Sciences at the Tisch Cancer Institute and Dubin Breast Center of Icahn School of Medicine at Mount Sinai in New York City. She received her MD and PhD degrees from Harvard Medical School and completed a...

Dr. Jaffee is an internationally recognized expert in cancer immunology with specific expertise in the pre-clinical and early clinical development of immunotherapies for breast and pancreatic cancers. She has developed novel vaccine approaches for the treatment of...

Dr. Lingtao Jin is an assistant professor in the Department of Anatomy and Cell Biology at the University of Florida. Dr. Jin received his PhD at the Institute of Biophysics, Chinese Academy of Sciences, China. He completed his postdoctoral training in Dr. Sumin Kang’s...

Benita Katzenellenbogen is Swanlund Professor of Physiology, Cell and Structural Biology, and director of a breast cancer research group at the University of Illinois at Urbana-Champaign. She is an internationally known endocrinologist and cancer researcher and has...

Dr. John Katzenellenbogen, Swanlund Professor of Chemistry, directs a research program at the University of Illinois at Urbana-Champaign that spans chemistry, biology, and medical applications with a particular focus on the action of estrogens in breast cancer. He is...

Dr. Annette R. Khaled joined the faculty of the University of Central Florida (UCF) College of Medicine (COM) after completing her pre-doctoral studies at the University of Florida and her post-doctoral studies at the National Cancer Institute (NCI). She is the...

Dr. Seema A. Khan is Professor of Surgery in the Feinberg School of Medicine at Northwestern University, and the Bluhm Family Professor of Cancer Research. She is the Co-leader of the Women’s Cancer Research Program at the Robert H. Lurie Comprehensive Cancer Center....

Thomas Kipps, MD, PhD, is Professor of Medicine, Evelyn and Edwin Tasch Chair in Cancer Research, and Deputy Director of Research Operations at the UC San Diego Moores Cancer Center. He received his MD and PhD. in Immunology from Harvard University and had his...

Panagiotis A. Konstantinopoulos, MD, PhD is Director of Translational Research and Attending Oncologist in the Gynecologic Oncology Program at Dana-Farber Cancer Institute, and an Associate Professor of Medicine at Harvard Medical School. His translational research...

Ian Elliott Krop, MD, PhD, is the Chief of Breast Medical Oncology and the Director of Clinical Research for the Breast Oncology Program at Dana-Farber Cancer Institute. He is also an Associate Professor of Medicine at Harvard Medical School. Dr. Krop is a...

Dr. Kuhn is a scientist and entrepreneur with a career long commitment in personalized medicine and individualized cancer patient care. He is focused on the redesign of cancer care.Dr. Kuhn is a Professor at USC, a founding member of a new Institute of Convergent...

Joshua LaBaer is one of the nation's foremost investigators in the rapidly expanding field of personalized medicine. Formerly director of the Harvard Institute of Proteomics (HIP), he was recruited to ASU's Biodesign Institute as the first Piper Chair in Personalized...

Karen Liby earned her PhD from the University of Cincinnati and then worked with Michael B. Sporn, a pioneer in the field of chemoprevention, at Dartmouth Medical School for 12 years. She recently started an Associate Professor position focused on drug discovery...

Dr. Lin is a medical oncologist at Dana-Farber Cancer Institute (DFCI) and Assistant Professor of Medicine at Harvard Medical School. Dr. Lin received her medical degree at Harvard Medical School and subsequently completed her residency in Internal Medicine at Brigham...

Dr Lindeman, a clinician-scientist, is Joint Head of the Stem Cells and Cancer Division at the Walter and Eliza Hall Institute of Medical Research (‘WEHI’); medical oncologist at the Peter MacCallum Cancer Centre and Royal Melbourne Hospital; Professorial Fellow in the...

Marc E. Lippman, MD, MACP FRCP is a professor of Oncology and co-directs the breast cancer program at the Lombardi Comprehensive Cancer Center at Georgetown University. Prior to that he was the Kathleen and Stanley Glaser Professor of Medicine at the University of...

Sherene Loi MD, PhD, is a clinician scientist and medical oncologist specializing in the treatment of breast cancer. She also leads a lab that focuses on understanding the genomic and immune interface in breast cancer with the aim to investigate and develop novel...

Dr. Nir London is an Assistant Professor in the Department of Organic Chemistry at Weizmann Institute of Science, Israel. He received his B.S. degree in Computer Science and Computational Biology and was awarded a Ph.D. in Computational Structural Biology at The Hebrew...

Dr. Cynthia Ma obtained her MD from Beijing Medical University in China and subsequently PhD in Developmental Biology from the University of Cincinnati. She completed her Internal Medicine residency from New Hanover Regional Medical Center at North Carolina followed by...

Dr. Mariana Chavez MacGregor is a medical oncologist with a clinical practice dedicated to the care of patients with breast cancer. After finishing medical school at the Universidad Nacional Autónoma de México, she obtained a Master in Sciences degree in Clinical...

Dr. Paul Macklin is an applied mathematician in the newly-established Department of Intelligent Systems Engineering at Indiana University. Dr. Macklin works with teams of clinicians, modelers, and biologists to develop and validate sophisticated computer models of...

Dr. Shyamala Maheswaran’s research is focused on defining the molecular mechanisms that drive breast cancer progression and metastasis.Breast cancer, initially confined to the primary site, eventually spreads to distal sites, including lung, liver, bone and...

Ursula A. Matulonis, MD, is Chief and Director of the Division of Gynecologic Oncology at the Dana-Farber Cancer Institute and Professor of Medicine at Harvard Medical School.  She is the first recipient of the Brock-Wilson Family Chair at the Dana-...

Heather McArthur, MD, MPH is Medical Director of Breast Oncology at Cedars-Sinai Medical Center. Dr. McArthur is a medical oncologist with a clinical practice dedicated to the care of patients with breast cancer. Her research activities are focused on innovations in...

Dr. Hayley McDaid received her PhD from the Queens University of Belfast, where she characterized the role of the cAMP-dependent protein kinase A signaling pathway in breast and ovarian cancer. These studies pioneered her present-day interest in targeted therapies...

Dr. Merghoub received his BA degree from University of Algiers, Algeria, and MS and PhD degrees with highest distinction from University of Paris, France. His thesis work focused on the study of genetic polymorphism in fetal hemoglobin gene in patients with sickle cell...

Otto Metzger received his MD from Federal University of Minas Gerais in his native Brazil. He then completed an internal medicine residency in a top-ranked general hospital, Hospital Felicio Rocho, and a medical oncology fellowship at the Brazilian National Cancer...

Gordon B. Mills, MD, PhD, is the Director of Precision Oncology, Director of SMMART trials, Associate Director, ad interim, for Clinical Research and holds the Wayne and Julie Drinkward Endowed Chair in Precision Oncology in the Knight Cancer Institute. In these roles...

Dr. Leslie L. Montgomery is a board-certified surgical oncologist specializing in breast cancer. She is Chief of the Division of Breast Surgery at Hackensack University Medical Center and the Co-Director of the Breast Service at John Theurer Cancer Center. She was...

Dr. Marsha A. Moses is the Julia Dyckman Andrus Professor at Harvard Medical School and the Director of the Vascular Biology Program at Boston Children's Hospital. She has made significant contributions to our understanding of the biochemical and molecular...

Tharcisse Mpunga, MD, MSc, has been the Medical Director of Butaro Hospital in Rwanda since 2009. He led the development of Butaro's acclaimed new hospital facility that opened in 2011, serving a predominantly poor, rural population of about 350,000 people in Northern...

Dr. Muss is an experienced clinician-scientist, a Professor of Medicine at the University of North Carolina School of Medicine, and the Director of the Geriatric Oncology Program at the UNC Lineberger Comprehensive Cancer Center Program. He has a major interest and...

Senthil K. Muthuswamy, Ph.D., is the Director of the Cell Biology Program at the Cancer Centre at Beth Israel Deaconess Medical Centre, Harvard Medical School. Dr. Muthuswamy received his Ph.D. from McMaster University, Canada and did his postdoctoral fellowship with...

Dr. Larry Norton, Senior Vice President, Office of the President; Medical Director, Evelyn H. Lauder Breast Center, Memorial Sloan Kettering Cancer Center is Professor of Medicine, Weill-Cornell Medical College. He is a founder of the Breast Cancer Research Foundation...

The main interest of Dr. Oesterreich’s research is to further our understanding of hormone action in women’s cancer in order to use this knowledge for improved diagnosis and endocrine treatment. Her studies have focused on breast cancer and in receptor action in...

Dr. Olopade's research interests are diverse and include: 1) treatment of breast cancer, especially in young or pregnant women; 2) familial cancers; 3) molecular genetics of cancer; 4) cancer risk assessment and chemoprevention; 5) breast cancer and minority...

Dr. Clodia Osipo received her PhD in Molecular and Cellular Biochemistry from Loyola University in 2002 while working under Dr. Allen Frankfater. Thereafter, she did her post-doctoral fellowship at the Robert H. Lurie Comprehensive Cancer Center of the Feinberg School...

Michael O'Donnell, PhD is the Anthony and Judith Evnin Professor at The Rockefeller University. He studies the molecular machinery that replicates DNA and duplicates the cellular genome. Several years ago his laboratory made the first discovery of a protein that...

Pier Paolo Pandolfi received his MD and PhD from the University of Perugia, Italy. He received post-graduate training at the National Institute for Medical Research and the University of London in the UK. Dr. Pandolfi presently holds the Reisman Endowed Chair of...

Ben Ho Park, MD, PhD, an internationally renowned breast cancer expert, was recently appointed as the co-leader of the Breast Cancer Research Program, Associate Director for Translational Research and Director of Precision Oncology at Vanderbilt-Ingram Cancer Center...

Dr. Barbara Parker is involved in the studies of novel personalized therapies for the treatment of breast cancer, the impact of diet and lifestyle on breast cancer outcomes, and the quality of life of breast cancer survivors. She is the principal investigator for the...

Ann Partridge, MD, MPH is a medical oncologist and clinical researcher focused on improving the care and outcomes of patients with cancer, with a focus on treatment, survivorship, and psychosocial issues facing women with breast cancer.  She founded and directs...

Mark D. Pegram, MD is a renowned clinician and scholar in breast cancer research and a leader in translational medicine. Dr. Pegram played a major role in developing the drug Herceptin as a treatment for HER2-positive breast cancer, which constitutes about 20 percent...

Dr. Perou is a member of the Lineberger Comprehensive Cancer Center at UNC, and the Scientific Director of the UNC Bioinformatics Core. He received his PhD in Cellular and Molecular Biology from the Department of Pathology at the University of Utah (1996) where he...

Dr. Pierce completed residency in Radiation Oncology at Pennsylvania and was a senior investigator at the National Cancer Institute (NCI). She joined the Department of Radiation Oncology at Michigan in 1992, where she is currently Professor of Radiation Oncology and...

Kornelia Polyak, MD, PhD is a Professor of Medicine at Dana-Farber Cancer Institute, Harvard Medical School, and is an internationally recognized leader in the breast cancer field. Research in Dr. Polyak’s laboratory is dedicated to the molecular analysis of human...

Elisa Port, MD, FACS joined Mount Sinai Hospital and its Icahn School of Medicine in 2010.  She serves as Chief of Breast Surgery and Director of the Dubin Breast Center. After receiving her medical degree from Mount Sinai in 1992, Dr. Port was a general surgery...

Simon Powell, MD, PhD is the Enid A. Haupt Professor and Chairman of the Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center. He is a member of the Molecular Biology Program of the Sloan-Kettering Institute, and Weill Cornell Graduate School of...

Aleix Prat received his medical degree from the University of Barcelona and became a medical oncologist at Hospital Vall d ́Hebron University Hospital in 2008. Aleix then completed a post-doctoral fellowship at the University of North Carolina at Chapel Hill under Prof...

Dr. Press is a Professor in the Department of Pathology and holds the Harold E. Lee Chair in Cancer Research at the University of Southern California’s Norris Comprehensive Cancer Center. Dr. Press is a board certified pathologist, directs the USC Breast Cancer...

Dr Pusztai is Professor of Medicine at Yale University and Chief of the Breast Medical Oncology Section at the Yale Cancer Center. He is also Co-Director of the Cancer Center Genomics and Genetics Program. Dr. Pusztai received his medical degree from the Semmelweis...

Dr. Rae received a BS in biology from the University of Pittsburgh and PhD in pharmacology from Georgetown University. In graduate school he combined his interest in breast cancer research with cutting-edge aspects of pharmacology including personalized medicine which...

Dr. Emily Ray is an Assistant Professor in the Division of Hematology-Oncology and a member of the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill. Her clinical work focuses on the care of patients with breast cancer. Her...

Meredith Regan, ScD is Associate Professor of Medicine, Division of Biostatistics, Dana-Farber Cancer Institute and Harvard Medical School. She is the Director, Statistical and Data Management Center for the International Breast Cancer Study Group (IBCSG), a Swiss non-...

Dr. David Rimm is a Professor in the Department of Pathology at the Yale University School of Medicine with a secondary appointment in Medicine (Oncology). He completed an MD-PhD at Johns Hopkins University Medical School followed by a Pathology Residency at Yale and...

Dr. Sandra Ryeom is an Assistant Professor in the Department of Cancer Biology at the Perelman School of Medicine at the University of Pennsylvania. Previously, Dr. Ryeom was a Research Associate at the Children’s Hospital and Assistant Professor at Harvard Medical...

Maurizio Scaltriti, PhD, is an Associate Laboratory Member in the Human Oncology...

Dr. Robert Schneider is the Albert Sabin Professor of Molecular Pathogenesis at NYU School of Medicine, an Associate Director of the NYU Cancer Institute, Breast Cancer Program Co-Director and Associate Dean for the Office of Therapeutics and Industry Alliances. He has...

Stuart J. Schnitt, M.D. is the Chief of Breast Oncologic Pathology for the Dana-Farber/Brigham and Women’s Cancer Center, Associate Director of the Dana-Farber Cancer Institute/Brigham and Women’s Hospital Breast Oncology Program, co-leader of the Dana Farber Harvard...

Dr. Dennis C. Sgroi is a Professor of Pathology, Harvard Medical School, and Co-Director of Breast Pathology and Member of the Center for Cancer Research at Massachusetts General Hospital.  He maintains an active clinical practice on the breast pathology...

Dr. Sheng completed her undergraduate studies in Biology and Psychology in the accelerated medical program at Rutgers University in 2010 while on full scholarship. She received her medical degree from the UMDNJ-New Jersey Medical School in 2013. She is currently in her...

Dr. Lois Shepherd is a Professor in the Department of Pathology and Molecular Medicine at Queen's University. She completed her medical school training at McGill and spent three years in England where her interest in hematology developed. She completed her training as...

Lawrence N. Shulman, M.D., is the Deputy Director for Clinical Services of the Abramson Cancer Center at the University of Pennsylvania, and Director of their newly formed Center for Global Cancer Medicine.  He has a leadership role in the strategic development of...

George W. Sledge Jr., MD, is Professor and Chief of Medical Oncology at Stanford University Medical Center.  He specializes in the study and treatment of breast cancer and directed the first large, nationwide study on the use of paclitaxel to treat advanced breast...

Ian E. Smith, MD, FRCP, FRCPE, is Professor of Cancer Medicine at The Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom. He is also Head of the Breast Unit at The Royal Marsden Hospital.His initial medical training was in Edinburgh and he...

Dr. Corey Speers is an assistant professor in the Department of Radiation Oncology at the University of Michigan Hospital and Health Systems in Ann Arbor, MI. He received his MD and PhD from Baylor College of Medicine where his research efforts were focused on the...

Michael B. Sporn received his MD degree at the University of Rochester, and then started a 35-year career at the National Institutes of Health, where he became the Chief of the Laboratory of Chemoprevention in the National Cancer Institute in 1978. In the 1980s his...

Dr. Fraser Symmans is Professor and Director of Research Operations in the Department of Pathology at MD Anderson Cancer Center, where he practices Breast Surgical Pathology and Cytopathology and also directs the Breast Cancer Pharmacogenomics Laboratory. He received...

Dr. Szallasi received his Doctor of Medicine degree from the University of Medicine in Debrecen, Hungary, in 1988. He did postdoctoral research in molecular pharmacology of cancer at the National Cancer Institute. As a faculty member, first at the Uniformed Services...

Allen Tannenbaum is an applied mathematician and presently Distinguished Professor of Computer Science and Applied Mathematics & Statistics at the State University of New York at Stony Brook. He is also Visiting Investigator of Medical Physics at Memorial Sloan...

Sohail Tavazoie graduated from the University of California at Berkeley and completed an MD-PhD program at Harvard-MIT, followed by residency training in Internal Medicine at Brigham & Women's Hospital at Harvard and medical oncology and postdoctoral fellowship...

Nadine Tung, MD is the Director of the Cancer Genetics and Prevention Program at Beth Israel Deaconess Medical Center (BIDMC) which she established in 1997 to evaluate patients and families with hereditary cancer syndromes. She is also a breast medical oncologist and a...

Naoto T. Ueno is a Professor of Medicine at The University of Texas MD Anderson Cancer Center; his research is in the area of inflammatory breast cancer/triple negative breast cancer, the molecular mechanism of metastasis (cancer microenvironment), and tumorigenicity...

Laura van ’t Veer, PhD, is a renowned molecular biologist, Principal Investigator of the Athena Breast Health Network at UCSF and Leader of the Breast Oncology Program in the Helen Diller Family Comprehensive Cancer Center. She is the former Head of Diagnostic Oncology...

Dr. Anna Vilgelm is a research assistant professor in pharmacology and cancer biology at Vanderbilt University. She received her MD from the Russian State Medical University in Moscow, Russia and her PhD is from the Engelhardt Institute of Molecular Biology in Moscow,...

Robert H. Vonderheide, MD, DPhil, is Director, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania and the John H. Glick, MD Abramson Cancer Center’s Director Professor. Dr. Vonderheide graduated from Oxford University as a Rhodes...

Dr. Liewei Wang received her medical degree from FuDan University Medical School, Shanghai, followed by a PhD degree in Pharmacology from the Mayo Clinic.  She trained in a leading national center for pharmacogenomics (PGx) research.  Currently Dr. Wang is...

Dr. Shaomeng Wang's primary research interest is the discovery and development of novel small-molecule therapeutics for the treatment of human breast cancer and other types of cancer focusing on targeting apoptosis and epigenetics pathways. Dr. Wang has built a...

Dr. Weaver is currently the Director of the Center for Bioengineering and Tissue Regeneration in the Department of Surgery, and is a Professor in the Departments of Surgery, Radiation Oncology and Bioengineering and Therapeutic Sciences at UCSF in San Francisco, CA.Dr...

Cold Spring Harbor Laboratory scientist Michael Wigler, PhD, in collaboration with James Hicks, PhD, is analyzing the genomes of women with breast cancer in research aimed at eliminating "trial-and-error" approaches to therapy. This work is leading to diagnostic tests...

Eric P. Winer, MD, is Professor of Medicine at Harvard Medical School and Chief, Division of Women's Cancers and the Thompson Senior Investigator in Breast Cancer Research at Dana-Farber Cancer Institute. He is also Co-Chair of the Breast Committee of the Alliance...

Dr. Wolchok is Chief of the Melanoma and Immunotherapeutics Service, Attending Physician at Memorial Sloan Kettering Cancer Center (MSKCC). Dr. Wolchok has helped establish MSKCC as a leader in the discovery and treatment of cancers with novel immunotherapies. Dr....

Dr. Antonio Wolff is a Professor of Oncology at Johns Hopkins University (JHU) and a member of the Johns Hopkins Kimmel Cancer Center (Baltimore, MD, USA). He received his medical degree at the Universidade Federal do Rio de Janeiro in Brazil and trained in medical...

Dr. Norman Wolmark, MD, is Chairman of  NSABP Foundation, a not-for-profit academic research organization with a nearly 60-year history of conducting ground-breaking research studies in breast and colorectal cancer.He is also Professor and Chairman of Human...

Dr. Gerburg Wulf is an Associate Professor of Medicine at Harvard Medical School and an Attending Physician in the Breast Oncology Group at Beth Israel Deaconess Medical Center (BIDMC) and the Dana-Farber Harvard Cancer Center (DFHCC).  She received her medical...

Jean Zhao is Professor of Biological Chemistry and Molecular Pharmacology at Harvard Medical School and Dana-Farber Cancer Institute (DFCI). Dr. Zhao’s research centers on understanding kinase signaling pathways in cancer. She has pioneered a new front in understanding...